Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Planta Med. 2010 May;76(7):713-8. doi: 10.1055/s-0029-1240682. Epub 2009 Dec 3.
As the insulin and leptin signaling pathway can be regulated by PTP1B, it has been suggested that compounds that reduce PTP1B activity or expression levels can be used for treating type 2 diabetes and obesity. In the course of our screening efforts on new PTP1B inhibitors, six new flavanones ( 1- 6) with dihydrofuran moiety and two known flavanones ( 7 and 8) were isolated from the stem bark of Erythrina abyssinica (Leguminosae). Their structures were elucidated on the basis of spectroscopic (including UV, CD, MS, 1D, and 2D NMR) and physicochemical analyses. With the exception of 3 and 5, the compounds inhibited PTP1B activity in an IN VITRO assay with IC (50) values ranging from 15.2 +/- 1.2 to 19.6 +/- 2.3 microM, whereas RK-682 as a positive control displayed an IC (50) value of 4.7 +/- 0.5 microM.
由于胰岛素和瘦素信号通路可以被 PTP1B 调节,因此有人提出,降低 PTP1B 活性或表达水平的化合物可用于治疗 2 型糖尿病和肥胖症。在我们对新型 PTP1B 抑制剂的筛选工作中,从非洲紫檀(豆科)的茎皮中分离得到了六个具有二氢呋喃部分的新黄烷酮(1-6)和两个已知的黄烷酮(7 和 8)。它们的结构是基于光谱(包括 UV、CD、MS、1D 和 2D NMR)和物理化学分析来阐明的。除了 3 和 5 之外,这些化合物在体外测定中抑制 PTP1B 活性,IC(50)值范围为 15.2 +/- 1.2 至 19.6 +/- 2.3 microM,而作为阳性对照的 RK-682 的 IC(50)值为 4.7 +/- 0.5 microM。